Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.


Journal

Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129

Informations de publication

Date de publication:
11 2020
Historique:
received: 03 10 2019
revised: 15 06 2020
accepted: 25 06 2020
pubmed: 2 7 2020
medline: 7 10 2021
entrez: 2 7 2020
Statut: ppublish

Résumé

The effects of PPIs on human sperm fertilizing capacity were poorly investigated although these drugs are widely over-used. Two publications retrospectively studied relationships between any PPI intake and sperm parameters from patients consulting at infertility clinics, but the conclusions of these reports were contradictory. Only two reports investigated the effects of lansoprazole and omeprazole on sperm motility and found lansoprazole to be deleterious and omeprazole to be neutral for sperm motility. The inconsistency of the PPI effect in the previous reports emphasizes the need for more basic research on human spermatozoa, taking into account the hypothesis that the different PPI drugs may have different effects on sperm physiology. Do PPIs, which are among the most widely sold drug in the word, impact negatively human sperm capacitation and sperm motility? The effects of PPIs on human sperm maturation and motility were analyzed by CASA, flow cytometry, and Western blot. We tested the impact of 6 different PPIs on human sperm motility and capacitation. We showed that pantoprazole, but not the other PPIs, decreased sperm progressive motility and capacitation-induced sperm hyperactivation. We therefore investigated further the effects of pantoprazole on sperm capacitation, and we observed that it had a significant deleterious effect on the capacitation-induced hyperpolarization of the membrane potential and capacitation-associated protein phosphorylation. Our results indicate that exposure to pantoprazole has an adverse effect on the physiological competence of human spermatozoa. As the capacitation process takes place within the female tract, our results suggest that PPIs intake by the female partner may impair in vivo sperm maturation and possibly fertilization. Moreover, the absence of adverse effect by PPIs on mouse sperm emphasizes the need to develop reprotox assays using human material to better assess the effects of medication intake on sperm physiology.

Sections du résumé

BACKGROUND
The effects of PPIs on human sperm fertilizing capacity were poorly investigated although these drugs are widely over-used. Two publications retrospectively studied relationships between any PPI intake and sperm parameters from patients consulting at infertility clinics, but the conclusions of these reports were contradictory. Only two reports investigated the effects of lansoprazole and omeprazole on sperm motility and found lansoprazole to be deleterious and omeprazole to be neutral for sperm motility. The inconsistency of the PPI effect in the previous reports emphasizes the need for more basic research on human spermatozoa, taking into account the hypothesis that the different PPI drugs may have different effects on sperm physiology.
OBJECTIVES
Do PPIs, which are among the most widely sold drug in the word, impact negatively human sperm capacitation and sperm motility?
MATERIALS AND METHODS
The effects of PPIs on human sperm maturation and motility were analyzed by CASA, flow cytometry, and Western blot.
RESULTS
We tested the impact of 6 different PPIs on human sperm motility and capacitation. We showed that pantoprazole, but not the other PPIs, decreased sperm progressive motility and capacitation-induced sperm hyperactivation. We therefore investigated further the effects of pantoprazole on sperm capacitation, and we observed that it had a significant deleterious effect on the capacitation-induced hyperpolarization of the membrane potential and capacitation-associated protein phosphorylation.
DISCUSSION AND CONCLUSION
Our results indicate that exposure to pantoprazole has an adverse effect on the physiological competence of human spermatozoa. As the capacitation process takes place within the female tract, our results suggest that PPIs intake by the female partner may impair in vivo sperm maturation and possibly fertilization. Moreover, the absence of adverse effect by PPIs on mouse sperm emphasizes the need to develop reprotox assays using human material to better assess the effects of medication intake on sperm physiology.

Identifiants

pubmed: 32609951
doi: 10.1111/andr.12855
doi:

Substances chimiques

2-Pyridinylmethylsulfinylbenzimidazoles 0
Proton Pump Inhibitors 0
Lansoprazole 0K5C5T2QPG
Rabeprazole 32828355LL
ilaprazole 776Q6XX45J
Pantoprazole D8TST4O562
Omeprazole KG60484QX9
Tenatoprazole RE0689TX2K

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1795-1804

Informations de copyright

© 2020 American Society of Andrology and European Academy of Andrology.

Références

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Medicine. 2012;9:e1001356.
De Kretser DM, Baker HW. Infertility in men: recent advances and continuing controversies. J Clin Endocrinol Metab. 1999;84:3443-3450.
World Health Organization. WHO laboratory manual for the examination and processing of human semen, 5th edn. Geneva: World Health Organization; 2010.
Schiffer C, Muller A, Egeberg DL, et al. Direct action of endocrine disrupting chemicals on human sperm. EMBO Rep. 2014;15:758-765.
Sipila P, Cooper TG, Yeung CH, et al. Epididymal dysfunction initiated by the expression of simian virus 40 T-antigen leads to angulated sperm flagella and infertility in transgenic mice. Mol Endocrinol. 2002;16:2603-2617.
Chabory E, Damon C, Lenoir A, et al. Epididymis seleno-independent glutathione peroxidase 5 maintains sperm DNA integrity in mice. J Clin Invest. 2009;119:2074-2085.
Rodriguez-Martinez H, Tienthai P, Suzuki K, Funahashi H, Ekwall H, Johannisson A. Involvement of oviduct in sperm capacitation and oocyte development in pigs. Reprod Suppl. 2001;58:129-145.
Rodriguez-Martinez H, Saravia F, Wallgren M, Roca J, Pena FJ. Influence of seminal plasma on the kinematics of boar spermatozoa during freezing. Theriogenology. 2008;70:1242-1250.
Burden HP, Holmes CH, Persad R, Whittington K. Prostasomes-their effects on human male reproduction and fertility. Hum Reprod Update. 2006;12:283-292.
Austin CR. The capacitation of the mammalian sperm. Nature. 1952;170:326.
Chang MC. Fertilizing capacity of spermatozoa deposited into the fallopian tubes. Nature. 1951;168:697-698.
Dukelow WR, Chernoff HN, Williams WL. Properties of decapacitation factor and presence in various species. J Reprod Fertil. 1967;14:393-399.
Davis BK. Timing of fertilization in mammals: sperm cholesterol/phospholipid ratio as a determinant of the capacitation interval. Proc Natl Acad Sci U S A. 1981;78:7560-7564.
Yanagimachi R. Fertility of mammalian spermatozoa: its development and relativity. Zygote. 1994;2:371-372.
Trevino CL, Serrano CJ, Beltran C, Felix R, Darszon A. Identification of mouse trp homologs and lipid rafts from spermatogenic cells and sperm. FEBS Lett. 2001;509:119-125.
Visconti PE, Galantino-Homer H, Ning X, et al. Cholesterol efflux-mediated signal transduction in mammalian sperm. beta-cyclodextrins initiate transmembrane signaling leading to an increase in protein tyrosine phosphorylation and capacitation. J Biol Chem. 1999;274:3235-3242.
Visconti PE, Ning X, Fornes MW, et al. Cholesterol efflux-mediated signal transduction in mammalian sperm: cholesterol release signals an increase in protein tyrosine phosphorylation during mouse sperm capacitation. Dev Biol. 1999;214:429-443.
Nakanishi T, Ikawa M, Yamada S, Toshimori K, Okabe M. Alkalinization of acrosome measured by GFP as a pH indicator and its relation to sperm capacitation. Dev Biol. 2001;237:222-231.
Zeng Y, Oberdorf JA, Florman HM. pH regulation in mouse sperm: identification of Na(+)-, Cl(-)-, and HCO3(-)-dependent and arylaminobenzoate-dependent regulatory mechanisms and characterization of their roles in sperm capacitation. Dev Biol. 1996;173:510-520.
Alvau A, Battistone MA, Gervasi MG, et al. The tyrosine kinase FER is responsible for the capacitation-associated increase in tyrosine phosphorylation in murine sperm. Development. 2016;143:2325-2333.
Arcelay E, Salicioni AM, Wertheimer E, Visconti PE. Identification of proteins undergoing tyrosine phosphorylation during mouse sperm capacitation. Int J Dev Biol. 2008;52:463-472.
Krapf D, Arcelay E, Wertheimer EV, et al. Inhibition of Ser/Thr phosphatases induces capacitation-associated signaling in the presence of Src kinase inhibitors. J Biol Chem. 2010;285:7977-7985.
Visconti PE, Bailey JL, Moore GD, Pan D, Olds-Clarke P, Kopf GS. Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and protein tyrosine phosphorylation. Development. 1995;121:1129-1137.
Visconti PE, Moore GD, Bailey JL, et al. Capacitation of mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are regulated by a cAMP-dependent pathway. Development. 1995;121:1139-1150.
Arnoult C, Albrieux M, Antoine AF, Grunwald D, Marty I, Villaz M. A ryanodine-sensitive calcium store in ascidian eggs monitored by whole-cell patch-clamp recordings. Cell Calcium. 1997;21:93-101.
Demarco IA, Espinosa F, Edwards J, et al. Involvement of a Na+/HCO-3 cotransporter in mouse sperm capacitation. J Biol Chem. 2003;278:7001-7009.
Felix R, Serrano CJ, Trevino CL, et al. Identification of distinct K+ channels in mouse spermatogenic cells and sperm. Zygote. 2002;10:183-188.
Munoz-Garay C, De La Vega-Beltran JL, Delgado R, Labarca P, Felix R, Darszon A. Inwardly rectifying K(+) channels in spermatogenic cells: functional expression and implication in sperm capacitation. DevBiol. 2001;234:261-274.
Buffone MG, Foster JA, Gerton GL. The role of the acrosomal matrix in fertilization. Int J Dev Biol. 2008;52:511-522.
Escoffier J, Jemel I, Tanemoto A, et al. Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice. J Clin Invest. 2010;120:1415-1428.
Tomes CN. Molecular mechanisms of membrane fusion during acrosomal exocytosis. Soc Reprod Fertil Suppl. 2007;65:275-291.
Darszon A, Beltran C, Felix R, Nishigaki T, Trevino CL. Ion transport in sperm signaling. Dev Biol. 2001;240:1-14.
Pettitt JM, Toh BH, Callaghan JM, Gleeson PA, Van Driel IR. Gastric parietal cell development: expression of the H+/K+ ATPase subunits coincides with the biogenesis of the secretory membranes. Immunol Cell Biol. 1993;71(Pt 3):191-200.
Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10:528-534.
Min JY, Ocampo CJ, Stevens WW, et al. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: possible role of the nongastric H, K-ATPase. J Allergy Clin Immunol. 2017;139(1):130-141.e11.
Wang J, Barbuskaite D, Tozzi M, Giannuzzo A, Sorensen CE, Novak I. Proton pump inhibitors inhibit pancreatic secretion: role of gastric and non-gastric H+/K+-ATPases. PLoS One. 2015;10:e0126432.
Wang G, Guo Y, Zhou T, et al. In-depth proteomic analysis of the human sperm reveals complex protein compositions. J Proteomics. 2013;79:114-122.
Ren D, Navarro B, Perez G, et al. A sperm ion channel required for sperm motility and male fertility. Nature. 2001;413:603-609.
Zeng Y, Clark EN, Florman HM. Sperm membrane potential: hyperpolarization during capacitation regulates zona pellucida-dependent acrosomal secretion. DevBiol. 1995;171:554-563.
Lopez-Gonzalez I, Torres-Rodriguez P, Sanchez-Carranza O, et al. Membrane hyperpolarization during human sperm capacitation. Mol Hum Reprod. 2014;20:619-629.
Huijgen NA, de Ridder MA, Verhamme KM, et al. Are proton-pump inhibitors harmful for the semen quality of men in couples who are planning pregnancy? Fertil Steril. 2016;106(7):1666-1672.e2.
Keihani S, Craig JR, Zhang C, et al. Proton-pump inhibitor use does not affect semen quality in subfertile men. Asian J Androl. 2017;20(3):290.
Banihani SA, Al-Khawalde AA. Omeprazole does not alter human sperm motility, viability or DNA integrity in vitro. Andrologia. 2019;51:e13260.
Banihani SA, Khasawneh FH. Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation. Res Pharm Sci. 2018;13:460-468.
Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil. 2013;19:25-35.
Shin JM, Sachs G. Differences in binding properties of two proton pump inhibitors on the gastric H+, K+-ATPase in vivo. Biochem Pharmacol. 2004;68:2117-2127.
Brenker C, Zhou Y, Muller A, et al. The Ca2+-activated K+ current of human sperm is mediated by Slo3. Elife. 2014;3:e01438.
Santi CM, Martinez-Lopez P, de la Vega-Beltran JL, et al. The SLO3 sperm-specific potassium channel plays a vital role in male fertility. FEBS Lett. 2010;584:1041-1046.
Navarro B, Kirichok Y, Clapham DE. KSper, a pH-sensitive K+ current that controls sperm membrane potential. Proc Natl Acad Sci U S A. 2007;104:7688-7692.
Singh AP, Rajender S. CatSper channel, sperm function and male fertility. ReprodBiomedOnline. 2015;30:28-38.
Suarez SS. Control of hyperactivation in sperm. Hum Reprod Update. 2008;14:647-657.
Yenisehirli A, Onur R. Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens. Pharmacol Res. 2006;54(6):397-405. https://doi.org/10.1016/j.phrs.2006.07.005
Gomez E, Aitken J. Impact of in vitro fertilization culture media on peroxidative damage to human spermatozoa. Fertil Steril. 1996;65:880-882.
Adler ID, Schmid TE, Baumgartner A. Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base. Mutat Res. 2002;504:173-182.
Banihani SA. Omeprazole and semen quality. Basic Clin Pharmacol Toxicol. 2016;118:181-183.
Scott D, Reuben M, Zampighi G, Sachs G. Cell isolation and genotoxicity assessment in gastric mucosa. Dig Dis Sci. 1990;35:1217-1225.
Jegla TJ, Zmasek CM, Batalov S, Nayak SK. Evolution of the human ion channel set. Comb Chem High Throughput Screen. 2009;12:2-23.
Lishko PV, Botchkina IL, Fedorenko A, Kirichok Y. Acid extrusion from human spermatozoa is mediated by flagellar voltage-gated proton channel. Cell. 2010;140:327-337.
Lishko PV, Kirichok Y. The role of Hv1 and CatSper channels in sperm activation. J Physiol. 2010;588:4667-4672.
Lishko PV, Kirichok Y, Ren D, Navarro B, Chung JJ, Clapham DE. The control of male fertility by spermatozoan ion channels. Annu Rev Physiol. 2012;74:453-475.
Tanner MR, Beeton C. Differences in ion channel phenotype and function between humans and animal models. Front Biosci (Landmark Ed). 2018;23:43-64.
Pestov NB, Romanova LG, Korneenko TV, et al. Ouabain-sensitive H, K-ATPase: tissue-specific expression of the mammalian genes encoding the catalytic alpha subunit. FEBS Lett. 1998;440:320-324.

Auteurs

Jessica Escoffier (J)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Bastien Arnaud (B)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Mayis Kaba (M)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.

Jean Pascal Hograindleur (JP)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Emilie Le Blévec (E)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Guillaume Martinez (G)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Isabelle Stévant (I)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.

Pierre F Ray (PF)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, Grenoble, France.

Christophe Arnoult (C)

Université Grenoble Alpes, Equipe "Génétique, Epigénétique et Thérapies de l'Infertilité", IAB, CNRS UMR 5309, Grenoble, France.

Serge Nef (S)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH